Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2009
06/17/2009EP2068855A2 Aromatic and heteroaromatic compounds useful in treating iron disorders
06/17/2009EP2068854A2 Business method to treat and/or prevent a gastric acid disorder with a proton pump inhibitor (ppi) and a cholinergic agonist to induce rapid onset of ppi action with or without food
06/17/2009EP2068853A2 Treatment of insulin resistance or diseases associated with insulin resistance with bicyclo[3.2.1]octans such as steviol and isosteviol
06/17/2009EP2068852A1 Antiviral compositions and use thereof
06/17/2009EP2068851A2 An enzyme regulating ether lipid signaling pathways
06/17/2009EP2068850A1 Use of a2a adenosine receptor agonists in the treatment of ischemia
06/17/2009EP2068849A2 Kinase inhibitors, and methods of using and identifying kinase inhibitors
06/17/2009EP2068848A2 Enhanced broad-spectrum uv radiation filters and methods
06/17/2009EP2068847A1 Preparation and composition of meloxicam transdermal drug delivery system
06/17/2009EP2068841A2 Novel formulations of proton pump inhibitors and methods of using these formulations
06/17/2009EP2068839A2 Pharmaceutical compositions comprising nilotinib or its salt
06/17/2009EP2068838A1 Pharmaceutical formulations comprising clopidogrel
06/17/2009EP2068836A2 Dry powder compound formulations and uses thereof
06/17/2009EP2068835A2 Imatinib compositions
06/17/2009EP2068831A2 Anti-migraine oral spray formulations and methods
06/17/2009EP2068827A2 Stabilization of lorazepam
06/17/2009EP2068825A1 Controlled release delivery system for nasal application of neurotransmitters
06/17/2009EP2068823A2 Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
06/17/2009EP2068819A2 Dendrimer compositions
06/17/2009EP2068812A1 Medicinal package
06/17/2009EP2068663A1 Satiety inducing products and a method of their production
06/17/2009EP2068660A2 Stable polyunsaturated fatty acid emulsions and methods for inhibitintg, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
06/17/2009EP2068630A2 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
06/17/2009EP2068629A2 Compositions and methods for treating cancer
06/17/2009EP2068628A2 Method of treating a condition associated with phosphorylation of task-1
06/17/2009EP2068622A2 Method and mixture for in-vivo photochemical cross-linking of collagen
06/17/2009EP2011497A4 Agent exhibiting a neurotropic, neuromodulator, cerebrovascular and anti- stroke activity
06/17/2009EP1877409B1 Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
06/17/2009EP1871381B1 Therapeutic substituted cyclopentanones
06/17/2009EP1866306B1 Imidazopyridine derivatives useful as inos inhibitors
06/17/2009EP1856102B1 Medicaments for alzheimer
06/17/2009EP1836166B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/17/2009EP1809276A4 Treatment method
06/17/2009EP1791423A4 Compositions and methods for the management of hyperproliferative dermatological conditions
06/17/2009EP1789419B1 Gyrase inhibitors and uses thereof
06/17/2009EP1789410B1 Methylene dipiperidine derivatives
06/17/2009EP1786468B1 Composition for promoting vascular smooth muscle relaxation
06/17/2009EP1740591B1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
06/17/2009EP1735320B1 Compounds and methods for treating dyslipidemia
06/17/2009EP1715742A4 Compositions and methods for sleep regulation
06/17/2009EP1712229B1 Fluconazole-tinidazole combination for the treatment of vaginal infections, composition thereof and preparation and use of same
06/17/2009EP1709056B1 Phosphoramidate derivatives
06/17/2009EP1664046B1 Aza-quinolinol phosphonate integrase inhibitor compounds
06/17/2009EP1633323B1 Ternary eutectic mixtures of local anesthetics
06/17/2009EP1620437B1 5,7-diaminopyrazolo¬4,3-d pyrimidines useful in the traetment of hypertension
06/17/2009EP1611088B1 Hydroxamates as therapeutic agents
06/17/2009EP1608653B1 SUBSTITUTED 8-PERFLUOROALKYL-6,7,8,9-TETRAHYDROPYRIMIDO (1,2- a) PYRIMIDIN-4-ONE DERIVATIVES
06/17/2009EP1603921B1 Thiadibenzoazulene derivatives for the treatment of inflammatory diseases
06/17/2009EP1602669B1 Antibody against a tumor-specific antigen as target
06/17/2009EP1566384B1 Novel azole derivatives
06/17/2009EP1565431B1 Cannabinoid receptor ligands
06/17/2009EP1542990B1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors
06/17/2009EP1521578B1 A novel use of rapamycin and structural analogues thereof
06/17/2009EP1499616B1 Heterocyclic compounds
06/17/2009EP1485381B1 Azolylaminoazine as inhibitors of protein kinases
06/17/2009EP1485375B1 Pyrimidine compounds
06/17/2009EP1472230B1 Ansamycins having improved pharmacological and biological properties
06/17/2009EP1439839B1 A combination comprising combretastatin and anticancer agents
06/17/2009EP1435957B1 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes
06/17/2009EP1435786A4 Pesticidal formulations
06/17/2009EP1390378B1 Pharmaceutically active uridine esters
06/17/2009EP1383736B1 Peptide deformylase inhibitors
06/17/2009EP1337518B1 Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
06/17/2009EP1322592B2 Substituted 1-aminobutan-3-ol derivatives
06/17/2009EP1267883B1 Bile secretion promoting composition for liver transplantation containing a 15-keto-prostaglandin
06/17/2009EP1171428B1 Fab i inhibitors
06/17/2009EP1095572B1 Use of an iodine-containing compound for producing an iodinated food product to prevent conditions caused by malfunctions of the thyroid gland
06/17/2009EP1015496B1 Divalent anti-t cells immunotoxins and use thereof
06/17/2009EP1004310B1 Gelled composition
06/17/2009EP0975595B1 Analogs of cocaine
06/17/2009EP0947196B1 Sustained-release prostaglandin i derivative preparation
06/17/2009CN101460179A Apparatus and methods for pain relief using ultrasound energized polymers
06/17/2009CN101460178A Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
06/17/2009CN101460177A Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores
06/17/2009CN101460176A Ocular allergy treatments
06/17/2009CN101460175A Compositions and methods for FGF receptor kinases inhibitors
06/17/2009CN101460174A Drug administration methods
06/17/2009CN101460173A Uses of DPP-IV inhibitors
06/17/2009CN101460172A Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
06/17/2009CN101460171A Use of vascular endothelial growth factor receptor inhibitors for the treatment of cancer
06/17/2009CN101460170A Combination of somatostatin-analogs with dopamine- or growth hormone receptor antagonist
06/17/2009CN101460169A Use of a cannabinoid cb1 receptor antagonist for preparation of drugs useful for the prevention and treatment of benign prostatic hypertrophy
06/17/2009CN101460168A Benzoimidazol-2-yl pyridines as modulators of the histamine H4 receptor
06/17/2009CN101460167A Thiazolyldihydrocyclopentapyrazoles for use as PI3-kinase inhibitors
06/17/2009CN101460166A Compositions and methods of use of ritonavir for treating hcv
06/17/2009CN101460165A Methods of reducing or eliminating salmonella in reptiles and/or their eggs
06/17/2009CN101460164A Compounds for diseases and disorders
06/17/2009CN101460163A Compositions and kits comprising a melatonin component and a chondroprotective component
06/17/2009CN101460162A Compositions and kits comprising a melatonin component and a flavanol component
06/17/2009CN101460161A Inhibition of alpha-synuclein toxicity
06/17/2009CN101460160A Compositions and kits comprising a melatonin component and an omega-3-fatty acid component
06/17/2009CN101460159A Fatigue-reducing agent
06/17/2009CN101460158A Spray composition for topical use for treating and/or preventing herpes simplex labial infections
06/17/2009CN101460157A Inhibitors of protein aggregation
06/17/2009CN101455676A Use of mussel polysaccharide in preparing anti-aging medicine or food
06/17/2009CN101455675A Ferulaic acid and astragaloside combination with kidney protection function and preparation method and use thereof
06/17/2009CN101455674A Halenia ellipitica D.Don. total di-phenylcumalin drop-pills for treating chronic hepatitis and preparation method thereof
06/17/2009CN101455673A Use of cinnamyl-(6'-O-alpha-L- arabopyranose)- O-beta-D-glucopyranoside in preparing antidepressant medicine
06/17/2009CN101455672A New medical use of cucurbitacin
06/17/2009CN101455671A Mifepristone medicinal preparation and preparation method thereof
1 ... 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 2712 2713 ... 7860